Abstract:

An adverse event following immunization (AEFI) is any untoward medical occurrence which follows immunization, and which does not necessarily have a causal relationship with the usage of the vaccine. Reporting of AEFI is suboptimal amongst healthcare workers (HCWs). This study aimed to determine health workers’ perception on AEFI reporting. A descriptive cross-sectional study was conducted among health workers in selected health facilities in Jigawa State. We used an Open data kit (ODK) based self-administered questionnaire to collect data on socio demographic characteristics, knowledge, and perception of respondents on AEFI. Data was analyzed using Statistical Package for Social Sciences (SPSS), for frequencies, associations and factors affecting HCWs perception of AEFI reporting at 5% significance (p-value<0.05) and 95% confidence interval. Perception was graded as: poor<50%, fair 50–70% and good ≥70%. Of the 400 respondents, 227(56.8%) had good perception. Building public trust in immunization (94.8%), to enable proper diagnosis and management (94.0%), elicit training needs (94.0%) and reduce consequences of AEFI on health workers (86.0%) were the main reasons for reporting AEFI. The barriers to reporting AEFI were time constraints (51.6%), poor feedback (48.8%) and fear of consequences (41.0%). AEFI knowledge (AOR 2.312, p=0.018) and receipt of feedback on reported AEFIs (AOR 0.45, p=0.026) were independent predictors of good perception of AEFI. Only 57% of health workers had a good perception of AEFI. To improve reporting of AEFI, there is need to train heath workers and strengthen feedback mechanism of AEFI surveillance system.

References:

[1] World Health Organization (WHO), Health Equity, Accessed: 3 May 2022. https://www.who.int/data/health-equity/report_2018_immunization.

[2] Amarasinghe A., 2016, World Health Organization, Global Advisory Committee on Vaccine Safety. Global manual on surveillance of adverse events following immunization. http://apps.who.int/iris/bitstream/10665/206144/1/9789241507769_eng.pdf Accessed 29 December 2020.

[3] McClenathan B. M., Edwards K. M., 2019, Vaccine safety: An evolving evidence‐based science. Br J Clin Pharmacol, 85(12):2649–2651.

[4] Mark K., 2022, Children’s Vaccine Program: The Case for Childhood Immunization; (5).

[5] World Health Organization, Vaccines, and immunization, Accessed: 23 April 2022. https://www.who.int/health-topics/vaccines-and-immunization.

[6] World Health Organization, Vaccine Safety Basics, Accessed 21 December 2020. https://vaccine-safety-training.org/investigation.html.

[7] World Health Organization, 2008, Reaching Every District Approach. http://www.who.int/bulletin/volumes/86/3/07-042127/en/.

[8] World Health Organization, Adverse events following immunization, Accessed 29 December 2020. https://www.who.int/vaccine_safety/initiative/tech_support/Part-3.pdf?ua=1.

[9] The Global Vaccine Safety Initiative (GVSI), Accessed 23 April 2022. https://www.who.int/initiatives/the-global-vaccine-safety-initiative.

[10]  Lei J., Balakrishnan M.R., Gidudu J. F., Zuber P. L. F., 2018, Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015 | Elsevier Enhanced Reader, doi: 10.1016/j.vaccine. 02.012.

[11]  World Health Organisation, 2011, Global Vaccine Action Plan 2011-2020.

[12]  Siddiqui M., Salmon D. A., Omer S. B., 2013, Epidemiology of vaccine hesitancy in the United States. Hum Vaccines Immunother, 9(12):2643–2648.

[13]  Akanmori B. D., Traore T., Balakrishnan M., Maure C., Zuber P., Mihigo R., 2018, Vaccine Safety and Pharmacovigilance in the African Region: Recent updates. J Immunol Sci. specialissue (1). https://www.immunologyresearchjournal.com/articles/vaccine-safety-and-pharmacovigilance-in-the-african-region-recent-updates.html. Accessed 23 April 2022.

[14]  Orji C.J., Chime O. H., Ugwuonah C., 2020, Incidence and Pattern of Adverse Events Following Immunization in the 2017/2018 Measles Vaccination Campaign in Nigeria. Online J Health Allied Sci OJHAS,18(4). http://hinaring.summon.serialssolutions.com/2.0.0/link/0/.

[15]  Gbenewei E., Nomhwange T., Taiwo L., Ayodeji I, Yusuf K., Jean Baptiste A. E., et al., 2021, Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign. Vaccine, 39:C82–C88.

[16]  Mehmeti I., Nelaj E., Simaku A., Tomini E., Bino S., 2017, Knowledge, practice, and approaches of health professionals to adverse events following immunization and their reporting in Albania. Heliyon, 3(6): e00331–e00331.

[17]  Mohammed L. A., Aliyu A. A., Maiha B. B., Isa A., 2018, Knowledge, perception, and reporting attitude of adverse effects following immunization among primary healthcare workers in sabon gari local government area Zaria, Kaduna State, Nigeria. Niger J Basic Clin Sci15(1):81.

[18]  Ogunyemi R., Odusanya O., 2016, A survey of knowledge and reporting practices of primary healthcare workers on adverse experiences following immunisation in alimosho local government area, Lagos. Niger Postgrad Med J, 23:79.

[19]  Umar A., Sufiyan M., Tukur D., Onoja-Alexander M., Amadu L., Bashir S., 2020, Knowledge of Adverse Events Following Immunization Reporting Tool and System Among Primary Healthcare Workers in Jigawa State. Infect Control Hosp Epidemiol, 41(S1):s308–s308.

[20]  M Oche O., 2020, Knowledge, Attitude and Reporting Practices on Adverse Events Following Immunization among Routine Immunization Service Providers in Health Facilities of Sokoto State, Nigeria. International Journal of Tropical Disease & Health.

[21]  Sani U. M., Oche M. O., Raji M. O., Ango U. M., Jiya N. M., 2019, Knowledge, Attitude and Reporting Practices on Adverse Events Following Immunization among Routine Immunization Service Providers in Health Facilities of Sokoto State. Nigeria. Int J Trop Dis Health,1–14.

[22]  Laryea E. B., Frimpong J. A., Noora C. L., Tengey J., Bandoh D., Sabblah G., et al., 2022, Evaluation of the adverse events following immunization surveillance system, Ghana 2019. PLOS ONE, 17(3):e0264697.

[23]  Ogunyemi A., 2016, Survey of knowledge and reporting practices of primary healthcare workers on adverse experiences following immunisation in alimosho local government area, Lagos. Accessed 21 December 2020. https://www.npmj.org/article.asp?issn=1117-1936 volume 23; issue 2.

[24]  Yamoah P., Bangalee V., Oosthuizen F., 2019, Knowledge and Perceptions of Adverse Events Following Immunization among Healthcare Professionals in Africa: A Case Study from Ghana. Vaccines Basel, 7(1):28.

[25]  World Health Organization, Adverse events following immunization (AEFI), Accessed: 5 April 2022. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/health-professionals-info/aefi.

[26]  National Primary Health Care Development Agency, 2018, Nigeria Field Guide on Surveillance of Adverse Events Following Immunization (AEFI) and Response.